China Pharma Holdings, Inc.

CPHIAMEXHealthcare● Active

$0.71

$-0.01(-0.82%)

Market Cap$2256873

P/E Ratio—

52W High$2.05

52W Low$0.38

Avg Volume277K

Open$0.72

Beta1.00

Overview

China Pharma Holdings, Inc. (CPHI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CPHI · net income · updated Jun 9, 2026

Core profitability metrics

CPHI · net income · margin · TTM · CAGR

Net income was −$3.2M for FY2025 (fiscal year ending 2025-12-31), up 32.7% year-over-year. Net profit margin was -76.9%. Based on available data, China Pharma Holdings, Inc. has been profitable since at least 2011.

FY2025 Net Income−$3.2M▲ +32.7% YoY

Trailing 12M (TTM)−$3.5Mtrailing 4 quarters sum

Net Profit Margin-76.9%−$3.2M ÷ $4.1M

YoY Change+32.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · CPHI net income history · CPHI profit margin

Annual net income data

CPHI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$3.2M▲ +32.7%-76.9%$4.1M

FY2024Loss−$4.7M▼ 53.8%-104.6%$4.5M

FY2023Loss−$3.1M▲ +22.5%-43.9%$7.0M

FY2022Loss−$4.0M▼ 16.9%-49.0%$8.1M

FY2021Loss−$3.4M▼ 18.6%-35.3%$9.6M

Net income vs peers (Healthcare)

CPHI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

China Pharma Holdings, Inc.YOU

CPHI

−$3.2M+32.7%-76.9%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

China Pharma Holdings, Inc. (CPHI) reported net income of −$3.2M for FY2025 (fiscal year ending 2025-12-31), up 32.7% year-over-year. The net profit margin was -76.9% — meaning the company kept $-0.77 of every dollar of revenue as profit.

Based on available data, China Pharma Holdings, Inc. has been profitable since at least 2011. Net income reached a peak of $19.3M in FY2011. Data available for 15 fiscal years.

China Pharma Holdings, Inc.'s net profit margin was -76.9% for FY2025, based on the latest annual results.

Investors sometimes search for "China Pharma Holdings, Inc. net worth" — the company's market capitalization is a separate figure from CPHI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CPHI net income · 4 questions

China Pharma Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $3.2M for FY2025.

is CPHI profitabledoes CPHI make a profitCPHI profitabilityCPHI profitable company

▸ Source: FMP /income-statement · GAAP · China Pharma Holdings, Inc. · China Pharma Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026